{"id":"https://openalex.org/W2408239245","doi":"https://doi.org/10.1158/1535-7163.targ-15-c149","title":"Abstract C149: Next-generation sequencing of biopsy-free circulating tumor DNA revealed frequent actionable alterations in advanced hepatocellular carcinoma","display_name":"Abstract C149: Next-generation sequencing of biopsy-free circulating tumor DNA revealed frequent actionable alterations in advanced hepatocellular carcinoma","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2408239245","doi":"https://doi.org/10.1158/1535-7163.targ-15-c149","mag":"2408239245"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-15-c149","doi":"https://doi.org/10.1158/1535-7163.targ-15-c149","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-c149","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018352586","display_name":"Sadakatsu Ikeda","orcid":"https://orcid.org/0000-0003-1629-7171","observed_orcids":["https://orcid.org/0000-0003-1629-7171"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sadakatsu Ikeda","raw_affiliation_strings":["1University of California, San Diego, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Diego, La Jolla, CA;","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054365404","display_name":"Kimberly C. Banks","orcid":"https://orcid.org/0000-0002-1290-3114","observed_orcids":["https://orcid.org/0000-0002-1290-3114"]},"institutions":[{"id":"https://openalex.org/I4210100465","display_name":"Guardant (United States)","ror":"https://ror.org/013z4s422","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Banks","raw_affiliation_strings":["2Guardant Health, Inc., Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Guardant Health, Inc., Redwood City, CA","institution_ids":["https://openalex.org/I4210100465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014411546","display_name":"Richard Burnham Lanman","orcid":"https://orcid.org/0000-0001-8122-4329","observed_orcids":["https://orcid.org/0000-0001-8122-4329"]},"institutions":[{"id":"https://openalex.org/I4210100465","display_name":"Guardant (United States)","ror":"https://ror.org/013z4s422","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Lanman","raw_affiliation_strings":["2Guardant Health, Inc., Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Guardant Health, Inc., Redwood City, CA","institution_ids":["https://openalex.org/I4210100465"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["1University of California, San Diego, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Diego, La Jolla, CA;","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"12_Supplement_2","first_page":"C149","last_page":"C149"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.847000002861023},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9580000042915344},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/actionable-mutations","display_name":"actionable mutations","score":0.5450000166893005},{"id":"https://openalex.org/keywords/somatic-alterations","display_name":"somatic alterations","score":0.7089999914169312},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.6449999809265137},{"id":"https://openalex.org/keywords/ctnnb1","display_name":"CTNNB1","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cdkn2a","display_name":"CDKN2A","score":0.8149999976158142},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.8149999976158142},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.7120000123977661},{"id":"https://openalex.org/keywords/wnt-signaling","display_name":"Wnt signaling","score":0.4690000116825104},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.6480000019073486},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5220000147819519},{"id":"https://openalex.org/keywords/molecular-tumor-board","display_name":"molecular tumor board","score":0.5920000076293945},{"id":"https://openalex.org/keywords/guardant360","display_name":"Guardant360","score":0.7049999833106995},{"id":"https://openalex.org/keywords/mutant-allele-fraction","display_name":"mutant allele fraction","score":0.6840000152587891},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.8213834762573242},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.682793140411377},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.6456816792488098},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5182976126670837},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.5157395005226135},{"id":"https://openalex.org/C152110520","wikidata":"https://www.wikidata.org/wiki/Q14225730","display_name":"Cell-free fetal DNA","level":5,"score":0.49793338775634766},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48622217774391174},{"id":"https://openalex.org/C2779529041","wikidata":"https://www.wikidata.org/wiki/Q22349364","display_name":"Liquid biopsy","level":3,"score":0.47929543256759644},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44524309039115906},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.43115705251693726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3862101137638092},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33125048875808716},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.25415700674057007},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.17414993047714233},{"id":"https://openalex.org/C2778258057","wikidata":"https://www.wikidata.org/wiki/Q1136569","display_name":"Prenatal diagnosis","level":4,"score":0.0},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.0},{"id":"https://openalex.org/C172680121","wikidata":"https://www.wikidata.org/wiki/Q26513","display_name":"Fetus","level":3,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-15-c149","doi":"https://doi.org/10.1158/1535-7163.targ-15-c149","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-c149","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2601392964","https://openalex.org/W2787984882","https://openalex.org/W2792521300","https://openalex.org/W4286299624","https://openalex.org/W4379282504","https://openalex.org/W2946843169","https://openalex.org/W4379283089","https://openalex.org/W3217484849","https://openalex.org/W4282966781","https://openalex.org/W4387142633"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Treatment":[2],"options":[3],"for":[4,29,92,116],"advanced":[5,70,348,403],"hepatocellular":[6,71,404],"carcinoma":[7,72],"(HCC)":[8],"are":[9,340],"limited.":[10],"Tumor":[11,167],"biopsy":[12],"is":[13,32,119,130,148,345,378],"not":[14,33,59],"routinely":[15],"performed":[16],"in":[17,55,97,106,125,139,203,226,327,347,357,402],"HCC":[18,27,56],"and":[19,52,108,145,220,243,263,274,310,319,350,376,416],"involves":[20],"risks.":[21],"As":[22],"such,":[23],"genomic":[24],"analysis":[25],"of":[26,39,83,101,136,193,373,393,409],"specimens":[28],"matched-targeted":[30,365],"therapies":[31],"often":[34],"an":[35],"option.":[36],"The":[37,87,112,128,256],"utility":[38,377],"cell-free":[40,126],"circulating":[41,395],"tumor":[42,396],"DNA":[43,397],"(ctDNA)":[44],"next-generation":[45],"sequencing":[46,392],"(NGS)":[47],"to":[48,122,132,289,332],"identify":[49],"somatic":[50,174],"alterations":[51,118,175,182,401],"target":[53],"therapy":[54,366],"patients":[57,68,151,157,171,247,362],"has":[58],"yet":[60],"been":[61],"characterized.":[62],"Methods:":[63],"We":[64],"prospectively":[65],"evaluated":[66],"14":[67],"with":[69,187,258,270,305],"(January":[73],"2015":[74,419],"-":[75,197,294],"June":[76],"2015)":[77],"using":[78],"a":[79,133,140,188,259,264,306,311,353],"ctDNA":[80,138,343],"NGS":[81],"panel":[82],"68":[84,98],"genes":[85],"(Guardant360).":[86],"test":[88,129],"sequences":[89],"complete":[90],"exons":[91],"single":[93,134],"nucleotide":[94],"variants":[95],"(SNVs)":[96],"genes,":[99,103],"amplifications":[100,223],"16":[102],"fusion":[104],"events":[105],"ALK/RET/ROS1/NTRK1,":[107],"specific":[109],"insertion/deletion":[110],"mutations.":[111],"mutant":[113,190],"allele":[114,191],"fraction":[115,192],"detected":[117],"calculated":[120],"relative":[121],"wild":[123],"type":[124],"DNA.":[127],"sensitive":[131],"fragment":[135],"mutated":[137],"10":[141],"ml":[142],"blood":[143],"sample,":[144],"analytic":[146],"specificity":[147],">99.9999%.":[149],"All":[150,170],"signed":[152],"informed":[153],"consent.":[154],"When":[155],"appropriate,":[156],"were":[158,201,224],"presented":[159],"at":[160,250,301],"the":[161,204,410],"UCSD":[162],"Moores":[163],"Cancer":[164,417,428],"Center":[165],"Molecular":[166,414],"Board.":[168],"Results:":[169],"(100%)":[172],"had":[173,249],"(SNVs":[176],"and/or":[177],"amplifications)":[178],"(average":[179],"=":[180,209],"3.6":[181],"per":[183],"patient":[184,257,304],"[range,":[185],"1-8])":[186],"median":[189],"0.29%":[194],"(range":[195],"0.1%":[196],"37.77%).":[198],"Point":[199],"mutations":[200],"identified":[202,225],"following":[205],"genes:":[206],"TP53":[207],"(N":[208],"8":[210],"patients),":[211],"CTNNB1":[212,265],"(4),":[213],"PTEN":[214,307],"(1),":[215,217,219,234,236,238,240,242],"CDKN2A":[216,260],"ARID1A":[218],"MET":[221,312],"(1);":[222],"CDK6":[227],"(2),":[228,230,232],"EGFR":[229],"MYC":[231],"BRAF":[233],"RAF1":[235],"FGFR1":[237],"CCNE1":[239],"PIK3CA":[241],"ERBB2/HER2":[244],"(1).":[245],"Eleven":[246],"(79%)":[248],"least":[251],"one":[252,328],"actionable":[253,400],"alteration":[254],"identified.":[255],"inactivating":[261,308],"mutation":[262,267,309,314],"activating":[266,313],"was":[268],"treated":[269],"palbociclib":[271],"(CDK4/6":[272],"inhibitor)":[273,318],"celecoxib":[275],"(COX-2/Wnt":[276],"inhibitor);":[277,322],"des":[278],"gamma-carboxy":[279],"prothrombin":[280],"level":[281],"decreased":[282],"by":[283,325],"84%":[284],"over":[285],"2":[286],"months":[287],"(1410":[288],"242":[290],"ng/ml":[291,331,334],"[normal:":[292,335],"0.0":[293],"7.4":[295],"ng/ml])":[296],"(alpha":[297],"fetoprotein":[298],"(AFP)":[299],"low":[300],"baseline).":[302],"Another":[303],"received":[315,364],"sirolimus":[316],"(mTOR":[317],"cabozantinib":[320],"(MET":[321],"AFP":[323],"declined":[324],"63%":[326],"month":[329],"(8320":[330],"3045":[333],"0-15":[336],"ng/ml]).":[337],"(Imaging":[338],"studies":[339],"pending).":[341],"Conclusion:":[342],"profiling":[344],"feasible":[346],"HCC,":[349],"may":[351],"provide":[352],"tissue":[354],"biopsy-free":[355,394],"alternative":[356],"these":[358],"difficult-to-biopsy":[359],"patients.":[360],"Two":[361],"who":[363],"demonstrated":[367],"rapid":[368],"biomarker":[369],"response.":[370],"Further":[371],"study":[372],"clinical":[374],"validity":[375],"ongoing.":[379],"Citation":[380],"Format:":[381],"Sadakatsu":[382],"Ikeda,":[383],"Kimberly":[384],"Banks,":[385],"Richard":[386],"B.":[387],"Lanman,":[388],"Razelle":[389],"Kurzrock.":[390],"Next-generation":[391],"revealed":[398],"frequent":[399],"carcinoma.":[405],"[abstract].":[406],"In:":[407],"Proceedings":[408],"AACR-NCI-EORTC":[411],"International":[412],"Conference:":[413],"Targets":[415],"Therapeutics;":[418],"Nov":[420],"5-9;":[421],"Boston,":[422],"MA.":[423],"Philadelphia":[424],"(PA):":[425],"AACR;":[426],"Mol":[427],"Ther":[429],"2015;14(12":[430],"Suppl":[431],"2):Abstract":[432],"nr":[433],"C149.":[434]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}